US blow for AstraZeneca
106113
Shares in AstraZeneca tumbled today after a key drug it has developed in the fight against strokes was provisionally rejected by US regulators.
557746
AstraZeneca Plc's experimental cancer drug AZD2281 has been given orphan drug status by the European Medicines Agency for treating women with ovarian cancer, Britain's second biggest drugmaker said on Tuesday.
527141
LONDON - Drug manufacturer AstraZeneca PLC announced Friday that trials of its new lung cancer drug found it didn&#39;t help patients live longer.
386632
THE US has lost half its annual supply of flu vaccines after American regulators declared all doses made in a British plant to be unsafe.
583059
LONDON, October 6  - AstraZeneca (AZN.ISE) has delayed the regulatory approval filing target for its diabetes drug, Galida, from 2006 to 2007, while admitting that its anti-blood clotting drug, Exanta, was unlikely to receive the US
45410
AstraZeneca Plc suffered its third setback in two months on Friday as lung cancer drug Iressa failed to help patients live longer in a major clinical trial, sending its shares down as much as 9.2 percent.
426995
AstraZeneca Plc suffered its third  setback in two months on Friday as lung cancer drug Iressa  failed to help patients live longer in a major clinical trial,  sending its shares down more than 8 percent.
347146
AstraZeneca reported a 12.5 percent drop in profit and Bristol-Myers Squibb posted a loss, albeit a narrower one.
619694
ASTRAZENECAâS anti-clotting drug Exanta is unlikely to win US approval in the near future, the company said as it revealed a delay with another new drug, Galida for diabetes.
619980
Leading London shares closed lower as drugmaker AstraZeneca suffered a heavy blow following a negative EU ruling on one of its patents.
207035
AstraZeneca Plc has withdrawn its  marketing application for lung cancer pill Iressa in Europe  after the drug failed to help patients live longer in a  clinical study, Europe's third largest drugmaker said on  Tuesday.
723080
Pfizer loses a patent case over its top compound.
426040
AstraZeneca Plc has won U.S. approval to  market its Nexium ulcer pill as a treatment that reduces the  risk of ulcers developing in patients on non-steroidal  anti-inflammatory drugs, it said on Monday.
22799
A U.S. panel of medical experts recommended on Friday that U.S. regulators reject AstraZeneca's   application to sell its anti-clotting drug Exanta.
115547
AstraZeneca Plc's experimental cancer  drug AZD2281 has been given orphan drug status by the European  Medicines Agency for treating women with ovarian cancer,  Britain's second biggest drugmaker said on Tuesday.
233492
Shares in drug giant AstraZeneca fall after a US medical panel recommends that regulators reject its new drug Exanta.
15055
AstraZeneca Plc (AZN) on Friday said US regulators did not approve its anti-clotting drug Exanta. The US Food and Drug Administration followed the advice of an advisory panel, which last